French Polynesia's health and social regulation agency. Its pharmacists handle requests to import medicines, it receives reports of medicine side effects, and its health observation office analyses death certificates.
The Agence de régulation de l'action sanitaire et sociale describes its mission as proposing public policy strategies and their financing in health, family and solidarity, medico-social action and social protection. Under Délibération n° 80-107 of 29 August 1980, French Polynesia's law on importing medicines, a request to import a human medicine that is not on the list of medicines admitted to the market in French Polynesia and has no equivalent in the French pharmacopoeia is made to the agency, and the authorisation is granted by the President of French Polynesia; the same goes for medicines prescribed outside the territory that a patient has sent in for personal use. Health professionals must report suspected side effects of medicines and vaccines to the agency. Its Bureau de veille sanitaire et de l'observation analyses death certificates, and the cancer registry's report for 2019 to 2021 uses its figures for 2019 as the most recent mortality data. OnCo did not read the territory's pharmacy law, Délibération n° 88-153 AT of 1988, so this record does not say how a medicine is admitted to the local market.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/